-+ 0.00%
-+ 0.00%
-+ 0.00%

JP Morgan Downgrades Upstream Bio to Neutral, Lowers Price Target to $8

Benzinga·06/12/2026 13:15:42
Listen to the news
JP Morgan analyst Tessa Romero downgrades Upstream Bio (NASDAQ:UPB) from Overweight to Neutral and lowers the price target from $35 to $8.